Clinical Trial News

A clinical trial is a research study that tests an investigational medicine or therapy in people to help us understand how well it works and how safe it is. Clinical trials contribute to the advancement of medicine with the goal of making life […]

ECHO is proud to announce our participation in the Revolution clinical trial (Apex-103) for solid tumors including pancreatic cancer, non-small cell lung cancer, and colorectal cancer. This groundbreaking national study has recently gained national attention for its encouraging early results […]

Peripheral neuropathy happens when the nerves that are located outside of the brain and spinal cord (peripheral nerves) are damaged. Peripheral neuropathy is a common side effect of many types of chemotherapy. The condition leads to tingling, burning, weakness, or numbness, most commonly […]

Dr. Curis joined the ECHO research team in October 2024. He attended the University of Rhode Island for his undergraduate bachelor’s degree in Biological and Health Sciences. He then attended Avalon University School of Medicine for his medical doctorate. He […]

Research is a core focus at Eastern Connecticut Hematology & Oncology (ECHO). For over 35 years, we have excelled at bringing the latest advancements and treatments to patients across Eastern Connecticut. This includes offering our patients the possibility to participate in promising […]

Beigene’s CELESTIAL Trial This clinical trial is for patients who have experienced progression of chronic lymphocytic leukemia.  The usual first line treatment includes a BTK inhibitor (ibrutinib, acalabrutinib, zanubrutinib , pirtoburtinib) or the combination of venetoclax with obinutuzumab.  Some patients […]